Gufic Biosciences Financials

NSE: GUFICBIO | BSE: 509079

₹444.90

₹5.55 (1.26%)

As on 04-Sep-2026 15:55IST

Market cap

₹4,467 Cr

Revenue (TTM)

₹981 Cr

P/E Ratio

60.8

P/B Ratio

6.5

Div. Yield

0 %

Income Statement (₹ Cr)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Operating Revenue	981.10	944.01	819.81	806.67	--	--
Total Income	983.29	946.66	823.43	808.84	--	--
Total Expenditure	816.46	792.67	683.71	659.37	--	--
EBITDA	164.64	151.34	136.10	147.30	--	--
Depreciation	30.82	30.83	21.06	17.02	--	--
EBIT	133.82	120.50	115.04	130.28	--	--
Interest	36.70	36.61	24.52	16.79	--	--
Other Income	2.19	2.66	3.63	2.18	--	--
Exceptional Items	--	--	--	--	--	--
Profit before Tax	99.31	86.55	94.14	115.67	--	--
Provision for Tax	25.86	22.34	24.49	29.54	--	--
Profit after Tax	73.45	64.21	69.65	86.14	--	--
Minority Interest	0.00	0.00	0.00	--	--	--
Share of Associate	--	--	--	--	--	--
Consolidated Profit	73.46	64.21	69.65	86.14	--	--

Liabilities (₹ Cr)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Shareholder's Funds	664.95	664.95	601.08	532.56	--	--
Minority Interest	0.00	0.04	--	--	--	--
Non-Current Liabilities	159.54	159.54	180.73	187.93	--	--
Current Liabilities	517.85	517.85	387.56	372.05	--	--
Total Liabilities	1,342.37	1,342.37	1,169.36	1,092.54	--	--

Assets (₹ Cr)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Non-Current Assets	497.69	540.26	544.84	492.06	--	--
Current Assets	802.12	802.12	624.52	600.48	--	--
Total Assets	1,342.38	1,342.37	1,169.36	1,092.54	--	--
Total Debt*	--	385.16	310.37	317.03	--	--
Net Current Assets	284.27	284.27	236.97	228.43	--	--
Contingent Liabilities	--	11.70	5.86	6.62	--	--

Cashflow (₹ Cr)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Cash From Operating Activities	--	45.14	122.57	-7.46	--	--
Cash Flow from Investing Activities	--	-30.96	-70.78	-102.39	--	--
Cash from Financing Activities	--	32.29	-37.20	82.38	--	--
Net Cash Inflow / Outflow	--	46.46	14.59	-27.47	--	--

Financials Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Adjusted EPS (₹)	7.32	6.40	6.95	8.59	--	--
Cash EPS (₹)	7.33	9.48	9.05	10.29	--	--
Adjusted Book Value (₹)	68.53	66.31	59.93	53.11	--	--
Dividend per Share (₹)	0.02	0.10	0.10	0.10	--	--
Cash Flow per Share (₹)	--	4.50	12.22	-0.74	--	--
Free Cash Flow per Share (₹)	--	-3.09	2.26	-13.94	--	--

Profitability Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
ROCE (%)	--	12.56	13.48	15.59	--	--
ROE (%)	11.33	10.14	12.29	16.17	--	--
ROA (%)	5.85	5.11	6.16	7.88	--	--
EBIT Margin (%)	13.64	12.77	14.03	16.15	--	--
Net Margin (%)	7.47	6.78	8.46	10.65	--	--
Cash Profit Margin (%)	--	7.78	8.24	10.97	--	--

Growth Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Revenue Growth (%)	16.70	15.15	1.63	--	--	--
EBIT Growth (%)	24.21	4.75	-11.70	--	--	--
Net Profit Growth (%)	20.26	-7.81	-19.14	--	--	--
EPS Growth (%)	20.26	-7.81	-19.14	--	--	--
Book Value Growth (%)	--	10.65	12.85	--	--	--

Valuation Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Price / Earnings	60.81	42.88	48.44	32.96	--	--
Price / Book Value	6.50	4.14	5.61	5.33	--	--
Dividend Yield (%)	0.02	0.04	0.03	0.04	--	--
EV/EBITDA	28.63	19.89	26.16	21.03	--	--
Close Price (₹)	407.05	273.80	336.30	282.50	--	--
High Price (₹)	448.00	409.00	504.25	364.90	--	--
Low Price (₹)	267.50	267.50	278.00	177.10	--	--
Market Cap (₹ Cr)	4,466.58	2,753.29	3,373.83	2,839.38	--	--

Solvency Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Debt to Equity	0.16	0.58	0.52	0.60	--	--
Short term debt to equity ratio	--	0.38	0.26	0.27	--	--
Current Ratio	1.55	1.55	1.61	1.61	--	--
Quick Ratio	0.92	0.92	1.05	1.08	--	--
Interest Coverage	3.71	3.36	4.84	7.89	--	--

Operating Efficiency Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Debtors to sales (%)	30.31	31.50	38.38	40.90	--	--
Asset Turnover	0.78	0.97	0.97	0.86	--	--
Receivable days	--	91.39	106.89	128.09	--	--
Inventory Days	--	80.84	69.22	77.83	--	--
Payable days	--	187.06	191.37	178.99	--	--
Cash Conversion Cycle	--	-14.82	-15.25	26.94	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement (₹ Cr)